Rodriguez-Abreu D, Bordoni A, Zucca E (2007) Epidemiology of hematological malignancies. Ann Oncol 18 Suppl 1:i3–i8. https://doi.org/10.1093/annonc/mdl443

Article  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.21834

Bispo JAB, Pinheiro PS, Kobetz EK (2020) Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med 10(6):a034819. https://doi.org/10.1101/cshperspect.a034819

Lin K, Jia H, Cao M, Xu T, Chen Z, Song X et al (2023) Epidemiological characteristics of leukemia in China, 2005–2017: a log-linear regression and age-period-cohort analysis. BMC Public Health 23(1):1647. https://doi.org/10.1186/s12889-023-16226-1

Article  PubMed  PubMed Central  Google Scholar 

Abaza Y, McMahon C, Garcia JS (2024) Advancements and challenges in the treatment of AML. Am Soc Clin Oncol Educ Book 44(3):e438662. https://doi.org/10.1200/edbk_438662

Article  PubMed  Google Scholar 

Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for cancer therapy. Cells 9(11):2496. https://doi.org/10.3390/cells9112496

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64(12):1471–1483. https://doi.org/10.1007/s00018-007-6497-0

Sluyter R (2017) The P2X7 receptor. Adv Exp Med Biol 1051:17–53. https://doi.org/10.1007/5584_2017_59

Zhang GP, Liao JX, Liu YY, Zhu FQ, Huang HJ, Zhang WJ (2024) Ion channel P2X7 receptor in the progression of cancer. Front Oncol 13:1297775. https://doi.org/10.3389/fonc.2023.1297775

Article  PubMed  PubMed Central  CAS  Google Scholar 

De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A et al (2019) The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene 38(19):3636–3650. https://doi.org/10.1038/s41388-019-0684-y

De Marchi E, Pegoraro A, Adinolfi E (2021) P2X7 receptor in hematological malignancies. Front Cell Dev Biol 9:645605. https://doi.org/10.3389/fcell.2021.645605

Article  PubMed  PubMed Central  Google Scholar 

Furini F, Giuliani AL, Parlati ME, Govoni M, Di Virgilio F, Bortoluzzi A (2019) P2X7 receptor expression in patients with serositis related to systemic lupus erythematosus. Front Pharmacol 10:435. https://doi.org/10.3389/fphar.2019.00435

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pegoraro A, Adinolfi E (2021) The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia. Purinergic Signal 17(3):319–321. https://doi.org/10.1007/s11302-021-09789-4

Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE (1998) Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 5(6):347–354

Google Scholar 

Di Virgilio F, Jiang LH, Roger S et al (2019) Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells. Methods Enzymol 629:115–150. https://doi.org/10.1016/bs.mie.2019.07.043

Roger S, Jelassi B, Couillin I, Pelegrin P, Besson P, Jiang LH (2015) Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives. Biochim Biophys Acta 1848(10 Pt B):2584–2602. https://doi.org/10.1016/j.bbamem.2014.10.029

Costa-Junior HM, Sarmento Vieira F, Coutinho-Silva R (2011) C terminus of the P2X7 receptor: treasure hunting. Purinergic Signal 7(1):7–19. https://doi.org/10.1007/s11302-011-9215-1

Article  CAS  Google Scholar 

Liang X, Samways DSK, Cox J, Egan TM (2019) Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus. J Biol Chem 294(33):12521–12533. https://doi.org/10.1074/jbc.RA119.009666

Migita K, Oyabu K, Terada K (2023) Rectification of ATP-gated current of rat P2X2 and P2X7 receptors depends on the cytoplasmic N-terminus. Biochem Biophys Res Commun 688:149213. https://doi.org/10.1016/j.bbrc.2023.149213

Article  PubMed  CAS  Google Scholar 

Sluyter R, Stokes L (2011) Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq 5(1):41–54. https://doi.org/10.2174/187221511794839219

Article  Google Scholar 

Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47(1):15–31. https://doi.org/10.1016/j.immuni.2017.06.020

Wiley JS, Sluyter R, Gu BJ, Stokes L, Fuller SJ (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78(5):321–332. https://doi.org/10.1111/j.1399-0039.2011.01780.x

Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262):735–738. https://doi.org/10.1126/science.272.5262.735

Article  CAS  Google Scholar 

Zhang XJ, Zheng GG, Ma XT et al (2004) Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk Res 28(12):1313–1322. https://doi.org/10.1016/j.leukres.2004.04.001

Article  CAS  Google Scholar 

Orioli E, De Marchi E, Giuliani AL, Adinolfi E (2017) P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses. Curr Med Chem 24(21):2261–2275. https://doi.org/10.2174/0929867324666170303161659

Article  CAS  Google Scholar 

Guerra Martinez C (2019) P2X7 receptor in cardiovascular disease: the heart side. Clin Exp Pharmacol Physiol 46(6):513–526. https://doi.org/10.1111/1440-1681.13079

Article  PubMed  CAS  Google Scholar 

Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S (2020) P2X7 in cancer: from molecular mechanisms to therapeutics. Front Pharmacol 11:793. https://doi.org/10.3389/fphar.2020.00793

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang LH, Caseley EA, Muench SP, Roger S (2021) Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal 17(3):331–344. https://doi.org/10.1007/s11302-021-09790-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hu SQ, Hu JL, Zou FL, Liu JP, Luo HL, Hu DX et al (2022) P2X7 receptor in inflammation and pain. Brain Res Bull 187:199–209. https://doi.org/10.1016/j.brainresbull.2022.07.006

Article  PubMed  CAS  Google Scholar 

Zheng H, Liu Q, Zhou S, Luo H, Zhang W (2024) Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases. Front Immunol 15:1345625. https://doi.org/10.3389/fimmu.2024.1345625

Article  PubMed  PubMed Central  CAS  Google Scholar 

Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F (2018) The P2X7 receptor: a main player in inflammation. Biochem Pharmacol 151:234–244. https://doi.org/10.1016/j.bcp.2017.12.021

Article  PubMed  CAS  Google Scholar 

El Idrissi IG, Podlewska S, Abate C, Bojarski AJ, Lacivita E, Leopoldo M (2024) Structure-activity relationships and therapeutic potential of purinergic P2X7 receptor antagonists. Curr Med Chem 31(11):1361–1403. https://doi.org/10.2174/0929867330666230403094538

Article  CAS  Google Scholar 

Barberà-Cremades M, Gómez AI, Baroja-Mazo A, Martínez-Alarcón L, Martínez CM, de Torre-Minguela C, Pelegrín P (2017) P2X7 receptor induces tumor necrosis factor-α converting enzyme activation and release to boost TNF-α production. Front Immunol 8:862. https://doi.org/10.3389/fimmu.2017.00862

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zou YT, Li JY, Chai JY, Hu YS, Zhang WJ, Zhang Q (2024) The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression. Biochem Biophys Res Commun 707:149513. https://doi.org/10.1016/j.bbrc.2024.149513

Article  PubMed  CAS  Google Scholar 

Nuñez-Ríos JD, Reyna-Jeldes M, Mata-Martínez E, Campos-Contreras ADR, Lazcano-Sánchez I Lazcano-Sánchez I et al (2024) Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells. PLos One 19(6):e0304062. https://doi.org/10.1371/journal.pone.0304062

Article  CAS  Google Scholar 

Janho Dit Hreich S, Hofman P, Vouret-Craviari V (2023) The role of IL-18 in P2RX7-mediated antitumor immunity. Int J Mol Sci 24(11):9235. https://doi.org/10.3390/ijms24119235

Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P et al (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72(12):2957–2969. https://doi.org/10.1158/0008-5472.Can-11-1947

Article  PubMed  CAS  Google Scholar 

Adinolfi E, De Marchi E, Orioli E, Pegoraro A, Di Virgilio F (2019) Role of the P2X7 receptor in tumor-associated inflammation. Curr Opin Pharmacol 47:59–64. https://doi.org/10.1016/j.coph.2019.02.012

Article  PubMed